| Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1· 8 … Y Lu, K Hajifathalian, M Ezzati, M Woodward, EB Rimm, G Danaei Lancet (London, England) 383 (9921), 970-983, 2013 | 974 | 2013 |
| Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study M Cuchel, EA Meagher, H du Toit Theron, DJ Blom, AD Marais, ... The Lancet 381 (9860), 40-46, 2013 | 816 | 2013 |
| Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an “FCS score” P Moulin, R Dufour, M Averna, M Arca, AB Cefalù, D Noto, L D'Erasmo, ... Atherosclerosis 275, 265-272, 2018 | 203 | 2018 |
| Molecular diagnosis of hypobetalipoproteinemia: an ENID review P Tarugi, M Averna, E Di Leo, AB Cefalù, D Noto, L Magnolo, L Cattin, ... Atherosclerosis 195 (2), e19-e27, 2007 | 192 | 2007 |
| Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy S Bertolini, L Pisciotta, C Rabacchi, AB Cefalù, D Noto, T Fasano, ... Atherosclerosis 227 (2), 342-348, 2013 | 168 | 2013 |
| A Novel Loss of Function Mutation of PCSK9 Gene in White Subjects With Low-Plasma Low-Density Lipoprotein Cholesterol T Fasano, AB Cefalu, E Di Leo, D Noto, D Pollaccia, L Bocchi, V Valenti, ... Arteriosclerosis, thrombosis, and vascular biology 27 (3), 677-681, 2007 | 166 | 2007 |
| Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia L Pisciotta, CP Oliva, AB Cefalù, D Noto, A Bellocchio, R Fresa, ... Atherosclerosis 186 (2), 433-440, 2006 | 160 | 2006 |
| Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins F Santilli, L Bucciarelli, D Noto, AB Cefalù, V Davì, E Ferrante, C Pettinella, ... Free Radical Biology and Medicine 43 (9), 1255-1262, 2007 | 151 | 2007 |
| Cystatin C levels are decreased in acute myocardial infarction: effect of cystatin C G73A gene polymorphism on plasma levels D Noto, AB Cefalu, CM Barbagallo, A Pace, M Rizzo, G Marino, ... International journal of cardiology 101 (2), 213-217, 2005 | 105 | 2005 |
| Effects of PCSK9 variants on common carotid artery intima media thickness and relation to ApoE alleles GD Norata, K Garlaschelli, L Grigore, S Raselli, S Tramontana, ... Atherosclerosis 208 (1), 177-182, 2010 | 101 | 2010 |
| Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study TR Tromp, ML Hartgers, GK Hovingh, AJ Vallejo-Vaz, KK Ray, H Soran, ... The Lancet 399 (10326), 719-728, 2022 | 98 | 2022 |
| A Novel APOB Mutation Identified by Exome Sequencing Cosegregates With Steatosis, Liver Cancer, and Hypocholesterolemia AB Cefalù, JP Pirruccello, D Noto, S Gabriel, V Valenti, N Gupta, R Spina, ... Arteriosclerosis, thrombosis, and vascular biology 33 (8), 2021-2025, 2013 | 97 | 2013 |
| Prevalence of ANGPTL3 and APOB gene mutations in subjects with combined hypolipidemia D Noto, AB Cefalu, V Valenti, F Fayer, E Pinotti, M Ditta, R Spina, G Vigna, ... Arteriosclerosis, thrombosis, and vascular biology 32 (3), 805-809, 2012 | 94 | 2012 |
| Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis [S] I Minicocci, S Santini, V Cantisani, N Stitziel, S Kathiresan, JA Arroyo, ... Journal of lipid research 54 (12), 3481-3490, 2013 | 93 | 2013 |
| Effect of the− 420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction GD Norata, M Ongari, K Garlaschelli, G Tibolla, L Grigore, S Raselli, ... Journal of internal medicine 262 (1), 104-112, 2007 | 90 | 2007 |
| Mutations in MTP gene in abeta-and hypobeta-lipoproteinemia E Di Leo, S Lancellotti, JY Penacchioni, AB Cefalù, M Averna, L Pisciotta, ... Atherosclerosis 180 (2), 311-318, 2005 | 81 | 2005 |
| Prevalence of overweight and obesity in a rural southern Italy population and relationships with total and cardiovascular mortality: the Ventimiglia di Sicilia project CM Barbagallo, G Cavera, M Sapienza, D Noto, AB Cefalu, M Pagano, ... International journal of obesity 25 (2), 185-190, 2001 | 80 | 2001 |
| Efficacy of lomitapide in the treatment of familial homozygous hypercholesterolemia: results of a real-world clinical experience in Italy L D’Erasmo, AB Cefalù, D Noto, A Giammanco, M Averna, P Pintus, ... Advances in therapy 34, 1200-1210, 2017 | 79 | 2017 |
| Spectrum of mutations in Italian patients with familial hypercholesterolemia: new results from the LIPIGEN study A Pirillo, K Garlaschelli, M Arca, M Averna, S Bertolini, S Calandra, ... Atherosclerosis Supplements 29, 17-24, 2017 | 78 | 2017 |
| Familial hypercholesterolemia: the Italian atherosclerosis society network (LIPIGEN) M Averna, AB Cefalu, M Casula, D Noto, M Arca, S Bertolini, S Calandra, ... Atherosclerosis Supplements 29, 11-16, 2017 | 75 | 2017 |
